1.
2.
Br J Psychiatry
; 219(1): 357-358, 2021 07.
Article
in English
| MEDLINE
| ID: mdl-35048857
ABSTRACT
Clozapine is under-used in the UK, and Casetta et al's recent paper in the BJPsych adds to a growing number of small studies that support the use of intramuscular clozapine to initiate and maintain treatment with oral clozapine. However, intramuscular clozapine remains unlicensed and, because of the risks associated with its administration, it should be used only cautiously before it can be adopted more widely into mainstream clinical practice.
Subject(s)
Antipsychotic Agents , Clozapine , Psychotic Disorders , Schizophrenia , Antipsychotic Agents/adverse effects , Clozapine/adverse effects , Humans , Psychotic Disorders/drug therapy , Schizophrenia/drug therapy
3.
BMJ
; 348: g3771, 2014 Jun 18.
Article
in English
| MEDLINE
| ID: mdl-24943739